Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 [WEBINAR] Trends in Peptides and Oligonucleotides – Choosing a Bartner CDMO | Contract Pharma

What are you searching for?

Sign in
Videos

[WEBINAR] Trends in Peptides and Oligonucleotides – Choosing a Bartner CDMO

This webinar which will take you through the foreseeable future of peptides and oligonucleotides.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Date: Thursday, February 24th
Time: 4:30pm UK / 5:30pm Switzerland / 8:30am PST

Peptide and oligonucleotide drugs are versatile therapeutics with a growing range of applications and many similarities in terms of manufacturing and regulation. New formulations often increase the complexity of the products and demand innovative solutions. Partnering with an experienced CDMO can support drug developers’ manufacturing needs and allow them to focus on the core of their developments.

Please join our webinar which will take you through the foreseeable future of peptides and oligonucleotides.

  • Tycho Leifels, Ph.D. – Group Leader Product Management at Bachem
  • Daniel Grotzky, Ph.D. – Head of Group Communication at Bachem
Register Now!

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters